1. HBW Insight
  2. >>Health

US FDA Meets Initial Deadlines In OTC Monograph Overhaul While It's Rebuilding The Program

 
• By Malcolm Spicer

Authorization was a long time coming for FDA to reform OTC monograph program and streamline process to change formulations, indications or labeling for large majority of drugs available nonprescription. As program is overhauled, monograph updates may seem to be coming just as slowly.

• Source: Alamy

Authorization was a long time coming for the US Food and Drug Administration to reform its OTC monograph program and streamline the process to change formulations, indications or labeling for the large majority of drugs available nonprescription.

As the program is overhauled, though, monograph updates may seem to be

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation